Literature DB >> 6695631

Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients.

E Schneider, K Hubener, P A Fischer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6695631

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  2 in total

1.  Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.

Authors:  H Baas; E Schneider; P A Fischer; G Japp
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

2.  Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism.

Authors:  E Schneider; H Baas; P A Fischer; G Japp
Journal:  J Neurol       Date:  1985       Impact factor: 4.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.